(DECT) AIM Products Trust - Overview
Etf: FLEX, Options, ETF
| Risk 5d forecast | |
|---|---|
| Volatility | 11.6% |
| Relative Tail Risk | 1.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.72 |
| Alpha | 1.93 |
| Character TTM | |
|---|---|
| Beta | 0.663 |
| Beta Downside | 0.683 |
| Drawdowns 3y | |
|---|---|
| Max DD | 13.26% |
| CAGR/Max DD | 1.05 |
Description: DECT AIM Products Trust December 16, 2025
DECT (NYSE ARCA: DECT) is a U.S.-based, non-diversified, defined-outcome ETF that aims to deliver a buffered return on the U.S. large-cap equity market by allocating virtually all of its assets to FLEX options that reference its underlying index.
FLEX options are exchange-traded contracts whose strike price, style, and expiration can be customized; the fund uses them to set a downside “buffer” (e.g., limiting losses to 10 %) while capping upside participation at a predetermined level through a December 2024 expiration.
Key quantitative details (as of the most recent filing) include an expense ratio of 0.55 %, assets under management of roughly $150 million, and an implied volatility on the underlying S&P 500 of about 18 % annualized; the ETF’s return correlation with the S&P 500 is approximately 0.94.
Primary economic drivers for DECT’s performance are the Federal Reserve’s monetary-policy stance (interest-rate trajectory), corporate earnings trends in large-cap sectors, and overall market risk sentiment as measured by the VIX; a sustained rate-hike environment could compress equity valuations, limiting upside capture, while a sharp market correction would activate the buffer protection.
Because the fund is non-diversified, concentration risk is significant-technology and consumer-discretionary stocks typically comprise more than 30 % of the underlying index exposure, and the top ten holdings alone account for a sizable share of risk.
For a deeper, data-driven scenario analysis of DECT’s risk-return profile, explore the interactive toolkit on ValueRay.
What is the price of DECT shares?
Over the past week, the price has changed by +0.16%, over one month by +0.30%, over three months by +3.79% and over the past year by +13.35%.
Is DECT a buy, sell or hold?
What are the forecasts/targets for the DECT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 40.5 | 9.3% |
DECT Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 121.4m USD (121.4m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 121.4m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 121.4m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.36% (E(121.4m)/V(121.4m) * Re(8.36%) + (debt-free company))
Discount Rate = 8.36% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)